Results 191 to 200 of about 25,222 (249)

Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion. [PDF]

Obes Pillars
Kyle M, Savastano DM, Sharpe TA, Kelly B.   +3 more
europepmc   +1 more source

A Review of Lifestyle Interventions Provided as an Adjunct to Obesity Management Medications. [PDF]

Obes Sci Pract
Chao AM, Asante R, Sersah ME, Jahangir UA, Peary A, Kudaya D.   +5 more
europepmc   +1 more source

Low dose naltrexone for fibromyalgia: case series demonstrating pain relief and other health benefits. [PDF]

Front Pain Res (Lausanne)
Junek A, Anderson M.
europepmc   +1 more source

Circulating Polyamines and Metabolic Changes Following a Mediterranean Diet with or Without Naltrexone/Bupropion in Breast Cancer Survivors: An Exploratory Secondary Analysis. [PDF]

Nutrients
Choi WJ, Lee YR, Lee YJ, Kwon YJ, Cho AR, Lee J, Lee JW.   +6 more
europepmc   +1 more source

Perceptions of Technology and Digital Health Tools Among Recently Incarcerated Adults With Opioid Use Disorder: Semistructured Interview Study. [PDF]

J Med Internet Res
Satcher MF, Saunders EC, Bell KD, Moore SK, Lee JD, Marsch LA.   +5 more
europepmc   +1 more source

Two-Year Biomarker Trends and Kidney/Mortality Outcomes After Semaglutide Versus Phentermine-Topiramate and Naltrexone-Bupropion in People With Obesity and Without Diabetes. [PDF]

Am J Ther
Chen SC, Liu KW, Huang YN, Meyerowitz-Katz G, Su PH.   +4 more
europepmc   +1 more source